208 related articles for article (PubMed ID: 24430620)
1. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
[TBL] [Abstract][Full Text] [Related]
2. HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapy.
Fevery B; Susser S; Lenz O; Cloherty G; Perner D; Picchio G; Sarrazin C
Antivir Ther; 2014; 19(6):559-67. PubMed ID: 24584086
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
[TBL] [Abstract][Full Text] [Related]
5. Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design.
Zitzer H; Heilek G; Truchon K; Susser S; Vermehren J; Sizmann D; Cobb B; Sarrazin C
J Clin Microbiol; 2013 Feb; 51(2):571-7. PubMed ID: 23241371
[TBL] [Abstract][Full Text] [Related]
6. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
7. Early phase viral kinetics of chronic hepatitis C patients receiving telaprevir-based triple therapy: a comparison of two real-time PCR assays.
Ogawa E; Furusyo N; Murata M; Toyoda K; Eiraku K; Shimizu M; Harada Y; Mitsumoto F; Takayama K; Okada K; Kainuma M; Hayashi J
Antiviral Res; 2013 Aug; 99(2):119-24. PubMed ID: 23684903
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.
Ogawa E; Furusyo N; Murata M; Shimizu M; Toyoda K; Hotta T; Uchiumi T; Hayashi J
Antivir Ther; 2017; 22(1):61-70. PubMed ID: 27632789
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
10. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pierce VM; Eversley JS; Tran TK; Rosenberg ES
Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
Inoue T; Hmwe SS; Shimada N; Kato K; Ide T; Torimura T; Kumada T; Toyoda H; Tsubota A; Takaguchi K; Wakita T; Tanaka Y
PLoS One; 2017; 12(1):e0170667. PubMed ID: 28118381
[TBL] [Abstract][Full Text] [Related]
13. Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment.
Wiesmann F; Naeth G; Berger A; Hirsch HH; Regenass S; Ross RS; Sarrazin C; Wedemeyer H; Knechten H; Braun P
Med Microbiol Immunol; 2016 Jun; 205(3):263-8. PubMed ID: 26666643
[TBL] [Abstract][Full Text] [Related]
14. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pyne MT; Hillyard DR
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
[TBL] [Abstract][Full Text] [Related]
16. Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patients.
Matsuura K; Tanaka Y; Hasegawa I; Ohno T; Tokuda H; Kurbanov F; Sugauchi F; Nojiri S; Joh T; Mizokami M
J Clin Microbiol; 2009 Feb; 47(2):385-9. PubMed ID: 19091819
[TBL] [Abstract][Full Text] [Related]
17. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
[TBL] [Abstract][Full Text] [Related]
18. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
[TBL] [Abstract][Full Text] [Related]
19. HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.
Butcher A; Aslam S; Hemyari P; Cowen U; Heilek G
J Clin Virol; 2014 Aug; 60(4):336-40. PubMed ID: 24881014
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
